“Improving the quality of life and to increasing the survival of patients with liver cirrhosis.”
“The Grifols Chair is focused on performing translational studies that improve our knowledge of the mechanisms of Chronic Liver Failure.”
“The clinical investigations of the EASL-CLIF Chair are performed by the EASL-CLIF Consortium, a network of 71 European University Hospitals.”
The EF CLIF is a private non-profit organization aimed to promote research and education in Chronic Liver Failure. The final objective of the Foundation is to improve the quality of life and to increase the survival of patients with liver cirrhosis.
The scientific activities of the EF CLIF are grouped in two Chairs of Research. The EASL-CLIF Chair is aimed at performing large observational, pathophysiological and therapeutic studies to increase our understanding of Chronic Liver Failure and to improve the management of patients with cirrhosis. The Grifols Chair is focused on performing translational studies that improve our knowledge of the mechanisms of Chronic Liver Failure and to promote.
Each chair has a specific tool to achieve their objectives. The clinical investigations of the EASL-CLIF Chair are performed by the EASL-CLIF Consortium, a network of close to a hundred European University Hospitals. The translational research projects of the Grifols Chair are performed by The European Network for Translational Research in Chronic Liver Failure (ENTR-CLIF), a network of research laboratories with interest in Liver Failure and facilities to perform translational research. The EASL-CLIF Consortium is already fully developed and operative. The Grifols Chair is still in a phase of early development.
A Board of Trustees, currently composed by Vicente Arroyo (MD, PhD), President of the Foundation, Mauro Bernardi (MD, PhD and Treasurer of the EASL), Javier Jorba (MD and Vice-President of Grifols) and Ignacio Calero (lawyer of Osborne Clarke Associates), is responsible for the direction of EF CLIF.
The Scientific Director of the EF CLIF is the head of the Research Program of the EF CLIF, final responsible of any study design, budged and coordination with of all other research activities and director of the Scientific Platforms of the Foundation (Data Management Center and Biobank). She/he is supported by the Scientific Advisory Board and reports directly to the Board of Trustees.
According to the rules of the EASL-CLIF Consortium, the scientific activities of the network of hospitals organized in the setting of the EF CLIF Chair are performed under the direction of a Chairman and Vice-Chairman and of an EASL-CLIF Consortium Steering Committee of 15 additional members. There is also an EASL-CLIF Consortium Assembly composed by the Steering Committee members and the hospital Coordinators.
The rules, organization, composition and scientific program of the Grifols Chair are currently being designed.